Value of distal compound muscle action potential duration prolongation in acute inflammatory demyelinating polyneuropathy: A european perspective

Muscle and Nerve

Volumn 43, Issue 5, 2011, Pages 751-755

  Rajabally, Yusuf A ^a   Nicolas, Guillaume ^b  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Acute inflammatory; Demyelinating polyneuropathy; Distal compound muscle action potential; Duration; Electrophysiology; Filter settings; Sensitivity; Specificity

Indexed keywords

ACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY; ADULT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISTAL COMPOUND MUSCLE ACTION POTENTIAL; ELECTROMYOGRAPHY; FEMALE; GIANT AXONAL NEUROPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE ACTION POTENTIAL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; OUTCOME ASSESSMENT; POLYNEUROPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SENSITIVITY AND SPECIFICITY; SENSORIMOTOR NEUROPATHY;

ACTION POTENTIALS; ELECTROMYOGRAPHY; EUROPE; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 79955562130     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21974     Document Type: Review

References (13)

1. Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barrésyndrome: clinical associations and outcome. Ann Neurol 1998;44:780-788.
2. Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985;8:528-539.
3. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al. Guillain-Barrésyndrome in northern China. Relationship to Campylobacter jejuni and anti-glycolipid antibodies. Brain 1995;118: 597-605.
4. Meulstee J, van der Meche, Dutch Guillain-BarréStudy Group. Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barrésyndrome. J Neurol Neurosurg Psychiatry 1995;59:482-486.
5. Italian Guillain-BarréStudy Group. The prognosis and main prognostic indicators of Guillain-Barrésyndrome. Brain 1996;119: 2053-2061.
6. Al-Shekhlee A, Hachwi R, Preston DC, Katirji B. New criteria for early electrodiagnosis of acute inflammatory demyelinating polyneuropathy. Muscle Nerve 2005;32:66-73.
7. Cleland JC, Malik K, Thaisetthawatkul P, Herrmann DN, Logigian EL. Acute inflammatory demyelinating polyneuropathy: contribution of a dispersed compound muscle action potential to electrodiagnosis. Muscle Nerve 2006;33:771-777.
8. Clouston PD, Kiers L, Zunigo G, Cros D. Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyneuropathy. Electroencephalogr Clin Neurophysiol 1994;93:245-254.
9. Isose S, Kuwabara S, Kokubun N, Sato Y, Mori M, Shibuya K, et al. Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies. J Peripher Nerv Syst 2009; 14:151-158.
10. Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. Eur J Neurol 2010;17:356-363.
11. Thaisetthawatkul P, Logigian EL, Herrmann DN. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology 2002;59:1526-1532.
12. Cleland JC, Logigian EL, Thaisetthawatkul P, Herrmann DN. Dispersion of the distal compound muscle action potential duration in chronic inflammatory demyelinating polyneuropathy and carpal tunnel syndrome. Muscle Nerve 2003;28:189-193.
13. Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain- Barrésyndrome. Arch Neurol 2001;58:913-917.